C71T
CANCELLED SECTION 71
17/04/2026
Voltar para busca
Dado oficial do USPTO
NOOMATO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
12/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
30/08/2018
Data de registro
01/10/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/04/2026
Última transação
12/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
33
Localização do titular
CH
Examinador
LAVACHE, LINDA M
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Naturalea SA
Representantes
ALEX PATEL PATEL & ALMEIDA, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical supplements for use in the manufacture of vitamins; vitamins for the manufacture of food supplements; antioxidants for the manufacture of food supplements; proteins for the manufacture of food supplements; enzymes for use in the manufacture of nutraceuticals; carbohydrates for use in the manufacture of nutraceuticals; chemical preparations for use in the pharmaceutical industry; chemical preserving agents for the pharmaceutical industry; vitamins for the food industry; proteins for the food industry; enzyme preparations for the food industry; probiotic bacterial cultures for the food industry; chemical preparations for use in the manufacture of pharmaceutical products; emollients for use in the manufacture of pharmaceutical products; antioxidants for the manufacture of pharmaceutical products; active chemical ingredients for manufacture of pharmaceutical products; biological preparations other than for medical usebiological preparations for use in industry and science
Classe 5
Veterinary preparations and substances for the treatment of gastrointestinal diseasesintestinal bacteria; biological preparations for veterinary use for the treatment of gastrointestinal diseaseinfectious diseases; dietetic substances for veterinary usedietary supplements for veterinary use; dietary supplements for persons with special diets; food supplements; vitamin supplements; nutritional supplements; anti-oxidant food supplements; probiotic supplements; nutritional and food supplements; Food supplements and dietetic preparationsdietary supplements; liquid herb-based food supplements; nutraceuticals for therapeutic use for the treatment of gastrointestinal diseases; nutraceutical products for animalsnutraceuticals for use as a dietary supplement; nutraceutical products for humansnutraceuticals for use as a dietary supplement; nutraceutical productsnutraceuticals used as dietary supplements; nutraceutical preparations for therapeutic or medical use for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal diseasesmusculo-skeletal disordershyperlipidemiaof infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disordersof damaged skin and tissue; Medical preparations for the treatment of gastrointestinal diseases; medical preparations for slimming; pharmaceutical preparationselixirs for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; medicated preparations for skin treatments; pharmaceutical substances and preparations with anti-inflammatory propertiesanti-inflammatories; plant preparations for medical useplant extracts for medical purposes; pharmaceutical preparations for immune system regulation; feed supplements for livestock for veterinary use; nutritional additives for animal feed for use as nutritional supplements for medical purposes; food supplements for animals; dietary supplements for pets; plant and herb extracts for medicinal use; medicinal plant extracts; plant extracts for pharmaceutical use; dietetic substances for medical usedietary supplements; pharmaceutical productspharmaceutical preparations for gastrointestinal diseases; plant extracts for medical use; food supplements for non-medical use; medicated food supplements
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/02/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/01/2020
FIMP
FINAL DISPOSITION PROCESSED
25/01/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/07/2019
PUBO
PUBLISHED FOR OPPOSITION
16/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2019
ALIE
ASSIGNED TO LIE
05/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/05/2019
RFNT
REFUSAL PROCESSED BY IB
17/01/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/12/2018
RFRR
REFUSAL PROCESSED BY MPU
29/12/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/12/2018
CNRT
NON-FINAL ACTION WRITTEN
17/12/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/12/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/10/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOOMATO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.